Ito Y - Search Results

1

Characterization of GATA-1(+) hemangioblastic cells in the mouse embryo.

Yokomizo T, Takahashi S, Mochizuki N, Kuroha T, Ema M, Wakamatsu A, Shimizu R, Ohneda O, Osato M, Okada H, Komori T, Ogawa M, Nishikawa S, Ito Y, Yamamoto M. Yokomizo T, et al. Among authors: ito y. EMBO J. 2007 Jan 10;26(1):184-96. doi: 10.1038/sj.emboj.7601480. Epub 2006 Dec 7. EMBO J. 2007. PMID: 17159898 Free PMC article.

2

Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations.

Yoshida T, Kanegane H, Osato M, Yanagida M, Miyawaki T, Ito Y, Shigesada K. Yoshida T, et al. Among authors: ito y. Am J Hum Genet. 2002 Oct;71(4):724-38. doi: 10.1086/342717. Epub 2002 Aug 26. Am J Hum Genet. 2002. PMID: 12196916 Free PMC article.

3

Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms.

Wee HJ, Huang G, Shigesada K, Ito Y. Wee HJ, et al. Among authors: ito y. EMBO Rep. 2002 Oct;3(10):967-74. doi: 10.1093/embo-reports/kvf193. Epub 2002 Sep 13. EMBO Rep. 2002. PMID: 12231506 Free PMC article.

4

Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development.

Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, Komori T, Ito Y, Littman DR. Taniuchi I, et al. Among authors: ito y. Cell. 2002 Nov 27;111(5):621-33. doi: 10.1016/s0092-8674(02)01111-x. Cell. 2002. PMID: 12464175 Free article.

5

Putative intermediate precursor between hematogenic endothelial cells and blood cells in the developing embryo.

Fraser ST, Ogawa M, Yokomizo T, Ito Y, Nishikawa S, Nishikawa S. Fraser ST, et al. Among authors: ito y. Dev Growth Differ. 2003 Feb;45(1):63-75. doi: 10.1046/j.1440-169x.2003.00675.x. Dev Growth Differ. 2003. PMID: 12630947

6

Functional analysis of RUNX2 mutations in cleidocranial dysplasia: novel insights into genotype-phenotype correlations.

Yoshida T, Kanegane H, Osato M, Yanagida M, Miyawaki T, Ito Y, Shigesada K. Yoshida T, et al. Among authors: ito y. Blood Cells Mol Dis. 2003 Mar-Apr;30(2):184-93. doi: 10.1016/s1079-9796(03)00020-2. Blood Cells Mol Dis. 2003. PMID: 12732182

7

Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera.

Huang G, Shigesada K, Wee HJ, Liu PP, Osato M, Ito Y. Huang G, et al. Among authors: ito y. Blood. 2004 Apr 15;103(8):3200-7. doi: 10.1182/blood-2003-07-2188. Epub 2003 Dec 24. Blood. 2004. PMID: 15070703 Free article.

8

Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog.

Yoshida CA, Yamamoto H, Fujita T, Furuichi T, Ito K, Inoue K, Yamana K, Zanma A, Takada K, Ito Y, Komori T. Yoshida CA, et al. Among authors: ito k, ito y. Genes Dev. 2004 Apr 15;18(8):952-63. doi: 10.1101/gad.1174704. Genes Dev. 2004. PMID: 15107406 Free PMC article.

9

Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model.

Iwasaki M, Kuwata T, Yamazaki Y, Jenkins NA, Copeland NG, Osato M, Ito Y, Kroon E, Sauvageau G, Nakamura T. Iwasaki M, et al. Among authors: ito y. Blood. 2005 Jan 15;105(2):784-93. doi: 10.1182/blood-2004-04-1508. Epub 2004 Sep 28. Blood. 2005. PMID: 15454493 Free article.

10

Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.

Yanagida M, Osato M, Yamashita N, Liqun H, Jacob B, Wu F, Cao X, Nakamura T, Yokomizo T, Takahashi S, Yamamoto M, Shigesada K, Ito Y. Yanagida M, et al. Among authors: ito y. Oncogene. 2005 Jun 30;24(28):4477-85. doi: 10.1038/sj.onc.1208675. Oncogene. 2005. PMID: 15856017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,131 results

Search Page

Filters